Gan & Lee Pharmaceuticals (SHA:603087) has removed Sun Cheng from his positions as chief financial officer and vice general manager, according to a Thursday filing with the Shanghai Stock Exchange.
The company said Sun's dismissal is a "strategic measure" designed to "optimize and adjust senior management personnel based on the company's strategic need for global upgrading of its innovative drug R&D, marketing, and investment and financing businesses."
The Chinese pharmaceutical company subsequently appointed Zhou Li as acting CFO, effective immediately, until a new CFO is appointed.
Zhou joined Gan & Lee's finance department in 2012 and has served as the director of the company's finance department since October 2019.
Comments